111 Capital Dexcom Inc Transaction History
111 Capital
- $518 Billion
- Q1 2025
A detailed history of 111 Capital transactions in Dexcom Inc stock. As of the latest transaction made, 111 Capital holds 16,385 shares of DXCM stock, worth $1.4 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
16,385Holding current value
$1.4 Million% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,081Shares Held
363MCall Options Held
5.4MPut Options Held
4.3M-
Vanguard Group Inc Valley Forge, PA47.5MShares$4.05 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.95 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.42 Billion0.05% of portfolio
-
Baillie Gifford & CO14.2MShares$1.21 Billion0.87% of portfolio
-
Capital Research Global Investors Los Angeles, CA12MShares$1.03 Billion0.19% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $33B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...